Dear Members,
Dear Members,
With spring started in many countries and several physical meetings being planned again, we are slowly confronted to go back to normal. Although lowering measures slowly will allow more fruitful scientific and networking interactions, it also still feels reluctant to move forward to a new normal. Once more we have to adapt ourselves as we also understand that combining an online society with inspiring networking to push the boundaries of science further is a really difficult exercise. Although hybrid environments will co-exist in the near future, a face-to-face interaction is highly warranted.
We are therefore excited to meet you all again at the Frontiers in CardioVascular Biomedicine (FCVB) 2022 congress in Budapest, Hungary from Friday 29 April to Sunday 1 May 2022. After not having a physical meeting for so long, we are looking forward to meet and interact and share latest insights with an inspiring program being ready.
Recently, we have hosted an ESC-webinar on “Induced-pluripotent stem cells (iPSC) technology for cardiac repair” in which Profs Wolfram Zimmermann and Nuria Monserrat presented the latest developments and their recent insights with an inspiring-interactive and large audience.
We hope to see you all soon in Budapest, but to have some exciting reading until then, we provide you here some interesting reads and translational results that will inspire us further.
On behalf of the Working Group nucleus,
Stefan Janssens, Chairperson 2020-2022 and Joost Sluijter, Communication Coordinator 2020-2022
Our mission: To reduce the burden of cardiovascular disease.